Per J. Nilsson

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten et al. · The Lancet Oncology · 2020 · 1.5K citations · Full text

Surgical Oncology, Radiation Therapy, Gastrointestinal Oncology +9

Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up

Rob Glynne‐Jones, Per J. Nilsson, C. Aschele et al. · European Journal of Surgical Oncology · 2014 · 484 citations

Esophageal Cancer, Gastrointestinal Oncology, Medicine +6

Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Rob Glynne‐Jones, Per J. Nilsson, C. Aschele et al. · Annals of Oncology · 2014 · 355 citations · Full text

Esophageal Cancer, Gastrointestinal Oncology, Medicine +6

Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery

Esmée A. Dijkstra, Per J. Nilsson, Geke A.P. Hospers et al. · Annals of Surgery · 2023 · 309 citations · Full text

Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial

Per J. Nilsson, Boudewijn van Etten, Geke A.P. Hospers et al. · BMC Cancer · 2013 · 294 citations · Full text